Why did Trump double steel tariffs?
How is Nvidia’s stock outlook for 2025?
What impact will Microsoft’s $400M Switzerland investment have?
Why are AI firms negotiating with major record labels?
How did Ukraine’s drone strike affect Russian airbases?
What’s behind Tesla’s sales rebound in Norway?
Why are U.S. steelmakers’ stocks surging now?
Combination treatment reduces risk of tumor progression in aggressive form of breast cancer, study shows
statnews.com/2025/05/31/trodelvy-keytruda-breast-cancer-gilead-merck-results
CHICAGO — A treatment that combines two different types of cancer-fighting medicines — Gilead Sciences’ Trodelvy with Merck’s Keytruda — reduced the risk of tumor progression by more than one-third in women with an aggressive form of breast cancer.
The results reported Saturday from the…
This story appeared on statnews.com, 2025-06-01 00:51:37.850000.